Eli Lilly and Co cut its 2019 profit forecast on Wednesday, hit by a recent trial failure of conditionally approved cancer treatment Lartruvo and costs related to its pending acquisition of Loxo Oncology.
from Reuters: Business News https://reut.rs/2GsgygR
Wednesday, February 6, 2019
Home »
business news
,
latest business news
» Eli Lilly cuts 2019 forecast on trial failure, Loxo deal
Eli Lilly cuts 2019 forecast on trial failure, Loxo deal
Why are UK borrowing costs rising and what does it mean for me?
Government borrowing costs have hit their highest level for several years - what does it mean for you? from BBC News https://ift.tt/CsMhmd...
0 comments:
Post a Comment